We have read with great interest the recent article from Silva et al about the clinical course of
COVID-19 in rheumatic disease. 1 In this matched cohort study of patients with COVID-19 …

Background & Aims Little is known about the efficacy and safety of induction therapy with
calcineurin inhibitors in combination with vedolizumab for patients with Crohn's disease …

Pneumonia imposes a significant clinical burden on people with immunocompromising
conditions. Millions of individuals live with compromised immunity because of cytotoxic …

The pathogenesis of tuberculosis (TB) remains poorly understood, as no more than 5–10%
of individuals infected with Mycobacterium tuberculosis go on developing clinical disease …

Background Tuberculosis (TB) is still one of the most important causes of death worldwide.
The lack of timely attention on TB diagnosis and treatment during the coronavirus disease …

Secukinumab, a fully human monoclonal antibody that selectively neutralizes interleukin‐
17A (IL‐17A), has been shown to have significant efficacy in the treatment of moderate to …

Tumor necrosis factor (TNF) inhibitors have improved a lot the treatment of numerous
diseases, with the well-known example of rheumatoid arthritis (RA). In the early 2000s …

Abstract Objective The Italian board for the TAilored BIOlogic therapy (ITABIO) reviewed the
most consistent literature to indicate the best strategy for the second-line biologic choice in …

Introduction Despite the availability of axial spondyloarthritis (SpA) recommendations
proposed by various rheumatology societies, we considered that a region‐specific guideline …

In higher vertebrates, mucosal sites at the border between the internal and external
environments, directly interact with bacteria, viruses, and fungi. Through co-evolution, hosts …